Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Latixa“
Suchtreffer
Begriffe & Kennungen
Ranexa (previously Latixa) · 4.5 · Dose adjustment of sensitive CYP3A4 substrates (e.g. simvastatin, lovastatin) and CYP3A4 substrates with a nar
Eintrag öffnenRanexa (previously Latixa) · 4.5 · Dose limitation of other statins, metabolised by CYP3A4 (e.g lovastatin), may be considered when taking Ranexa
Eintrag öffnenRanexa (previously Latixa) · 4.5 · Dose limitation of other statins, metabolised by CYP3A4 (e.g. lovastatin), may be considered when taking Ranex
Eintrag öffnenRanexa (previously Latixa) · 4.5 · Dose limitation of other statins, metabolised by CYP3A4 (e.g. lovastatin), may be considered when taking Ranex
Eintrag öffnenRanexa (previously Latixa) · 4.5 · Drugs transported by the Organic Cation Transporter-2 (OCT2): Plasma exposure of metformin (1000 mg twice dail
Eintrag öffnenRanexa (previously Latixa) · 4.5 · Drugs transported by the Organic Cation Transporter-2 (OCT2): Plasma exposure of metformin (1000 mg twice dail
Eintrag öffnenRanexa (previously Latixa) · 4.5 · Drugs transported by the Organic Cation Transporter-2 (OCT2): Plasma exposure of metformin (1000 mg twice dail
Eintrag öffnenRanexa (previously Latixa) · 4.5 · Effects of other medicinal products on ranolazine
Eintrag öffnenRanexa (previously Latixa) · 4.5 · Effects of other medicinal products on ranolazine
Eintrag öffnenRanexa (previously Latixa) · 4.5 · Effects of other medicinal products on ranolazine
Eintrag öffnenRanexa (previously Latixa) · 4.5 · Effects of ranolazine on other medicinal products
Eintrag öffnenRanexa (previously Latixa) · 4.5 · Effects of ranolazine on other medicinal products
Eintrag öffnenRanexa (previously Latixa) · 4.5 · Ranolazine is a moderate to potent inhibitor of P-gp and a mild inhibitor of CYP3A4, and may increase plasma c
Eintrag öffnenRanexa (previously Latixa) · 4.5 · Ranolazine is a moderate to potent inhibitor of P-gp and a mild inhibitor of CYP3A4, and may increase plasma c
Eintrag öffnenRanexa (previously Latixa) · 4.5 · Ranolazine is a moderate to potent inhibitor of P-gp and a mild inhibitor of CYP3A4, and may increase plasma c
Eintrag öffnenRanexa (previously Latixa) · 4.5 · Ranolazine is a substrate for P-gp. Inhibitors of P-gp (e.g. ciclosporin, verapamil) increase plasma levels of
Eintrag öffnenRanexa (previously Latixa) · 4.5 · Ranolazine is a substrate for P-gp. Inhibitors of P-gp (e.g. ciclosporin, verapamil) increase plasma levels of
Eintrag öffnenRanexa (previously Latixa) · 4.5 · Ranolazine is a substrate for P-gp. Inhibitors of P-gp (e.g. ciclosporin, verapamil) increase plasma levels of
Eintrag öffnenRanexa (previously Latixa) · 4.5 · Simvastatin: Simvastatin metabolism and clearance are highly dependent on CYP3A4. Ranexa 1000 mg twice daily i
Eintrag öffnenRanexa (previously Latixa) · 4.5 · Simvastatin: Simvastatin metabolism and clearance are highly dependent on CYP3A4. Ranexa 1000 mg twice daily i
Eintrag öffnen